Nutraceutical supplements for weight loss: A systematic review

Nutrition in Clinical Practice

Volumn 26, Issue 5, 2011, Pages 539-552

  Poddar, Kavita ^a   Kolge, Sanjivani ^a   Bezman, Lena ^b   Mullin, Gerard E ^c   Cheskin, Lawrence J ^a,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anti obesity agents; dietary supplements; obesity; weight loss

Indexed keywords

ANTIOBESITY AGENT; CAFFEINE; CAPSAICIN; CARBOHYDRATE; CARNITINE; CATECHIN; CHITIN; CHITOSAN; CONJUGATED LINOLEIC ACID; EPHEDRA EXTRACT; EPHEDRA SINICA EXTRACT; FATTY ACID; GARCINIA CAMBOGIA EXTRACT; GLUCOSE; GUAR GUM; INSULIN; ISPAGULA; MANNAN;

ABDOMINAL FAT; ANALGESIA; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; CHINESE MEDICINE; CISSUS QUADRANGULARIS; CORONARY ARTERY DISEASE; DECREASED APPETITE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY FIBER; DIETARY INTAKE; DYSLIPIDEMIA; ENERGY EXPENDITURE; EPHEDRA; EPHEDRA SINICA; FAT INTAKE; FATTY ACID OXIDATION; FENUGREEK; FOOD INTAKE; GARCINIA CAMBOGIA; GERMANDER; GINSENG; GLUCOSE BLOOD LEVEL; HOODIA GORDONII; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; INTESTINE ABSORPTION; KONJAC ROOT FIBER; LIPID ABSORPTION; LIPOGENESIS; LIVER TOXICITY; NONHUMAN; NUTRACEUTICAL SUPPLEMENT; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; OBESITY; OXIDATIVE STRESS; PHASEOLUS VULGARIS; PLANT; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SATIETY; SOUR ORANGE; STROKE; SYSTEMATIC REVIEW (TOPIC); TEA; WEIGHT CONTROL; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; DIETARY SUPPLEMENTS; HUMANS; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; WEIGHT LOSS;

EID: 80053237687     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533611419859     Document Type: Review

References (189)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010 ; 303: 235-241
2. Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am. 2010 ; 39: 1-7
3. Grimm ER, Steinle NI. Genetics of eating behavior: established and emerging concepts. Nutr Rev. 2011 ; 69: 52-60
4. Lake A, Townshend T. Obesogenic environments: exploring the built and food environments. J R Soc Promot Health. 2006 ; 126: 262-267 (Pubitemid 44614112)
5. Booth KM, Pinkston MM, Poston WS. Obesity and the built environment. J Am Diet Assoc. 2005 ; 105: S110 - S117
6. Davis MA, West AN, Weeks WB, Sirovich BE. Health behaviors and utilization among users of complementary and alternative medicine for treatment versus health promotion. Health Serv Res. 2011 ;:
7. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Rep. 2009 ; 18: 1-14
8. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med. 1993 ; 328: 246-252 (Pubitemid 23035311)
9. Saper RB, Eisenberg DM, Phillips RS. Common dietary supplements for weight loss. Am Fam Physician. 2004 ; 70: 1731-1738 (Pubitemid 39463386)
10. Blanck HM, Serdula MK, Gillespie C, et al. Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc. 2007 ; 107: 441-447 (Pubitemid 46281823)
11. Bertisch SM, Wee CC, McCarthy EP. Use of complementary and alternative therapies by overweight and obese adults. Obesity. 2008 ; 16: 1610-1615 (Pubitemid 351915110)
12. Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA. Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity. 2008 ; 16: 790-796 (Pubitemid 351465634)
13. Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008 ; 108 (10). 1716-1731
14. O'Neil CE, Nicklas TA, Zanovec M, Cho S. Whole-grain consumption is associated with diet quality and nutrient intake in adults: the National Health and Nutrition Examination Survey, 1999-2004. J Am Diet Assoc. 2010 ; 110: 1461-1468
15. Blanck HM, Gillespie C, Kimmons JE, Seymour JD, Serdula MK. Trends in fruit vegetable consumption among U.S. men and women, 1994-2005. Prev Chronic Dis. 2008 ; 5: A35
16. Nicklas TA, Farris RP, Myers L, Berenson GS. Dietary fiber intake of children and young adults: the Bogalusa Heart Study. J Am Diet Assoc. 1995 ; 95: 209-214
17. Ello-Martin JA, Roe LS, Ledikwe JH, Beach AM, Rolls BJ. Dietary energy density in the treatment of obesity: a year-long trial comparing 2 weight-loss diets. Am J Clin Nutr. 2007 ; 85: 1465-1477 (Pubitemid 46890413)
18. Ledikwe JH, Blanck HM, Kettel Khan L, et al. Dietary energy density is associated with energy intake and weight status in US adults. Am J Clin Nutr. 2006 ; 83: 1362-1368 (Pubitemid 44713068)
19. Kant AK, Graubard BI. Energy density of diets reported by American adults: association with food group intake, nutrient intake, and body weight. Int J Obes (Lond). 2005 ; 29 (8). 950-956 (Pubitemid 41076235)
20. Ledikwe JH, Blanck HM, Khan LK, et al. Low-energy-density diets are associated with high diet quality in adults in the United States. J Am Diet Assoc. 2006 ; 106: 1172-1180 (Pubitemid 44079972)
21. Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr. 2003 ; 78: 920-927 (Pubitemid 39663467)
22. Bes-Rastrollo M, Martínez-González MA, Sánchez- Villegas A, de la Fuente Arrillaga C, Martínez JA. Association of fiber intake and fruit/vegetable consumption with weight gain in a Mediterranean population. Nutrition. 2006 ; 22 (5). 504-511
23. Vioque J, Weinbrenner T, Castelló A, Asensio L, Garcia de la Hera M. Intake of fruits and vegetables in relation to 10-year weight gain among Spanish adults. Obesity. 2008 ; 16: 664-670 (Pubitemid 351328017)
24. Du H, van der A DL, Boshuizen HC, et al. Dietary fiber and subsequent changes in body weight and waist circumference in European men and women. Am J Clin Nutr. 2010 ; 91: 329-336
25. Jones JR, Lineback DM, Levine MJ. Dietary reference intakes: implications for fiber labeling and consumption: a summary of the International Life Sciences Institute North America Fiber Workshop, June 1-2, 2004, Washington, DC. Nutr Rev. 2006 ; 64: 31-38
26. United States Department of Agriculture. National Agricultural Library. In: Dietary, Functional, and Total Fiber. http://www.nal.usda.gov/fnic/DRI//DRI- Energy/339-421.pdf
27. Samra RA, Anderson GH. Insoluble cereal fiber reduces appetite and short-term food intake and glycemic response to food consumed 75 min later by healthy men. Am J Clin Nutr. 2007 ; 86: 972-979 (Pubitemid 47538298)
28. Lee YP, Mori TA, Sipsas S, et al. Lupin-enriched bread increases satiety and reduces energy intake acutely. Am J Clin Nutr. 2006 ; 84: 975-980 (Pubitemid 44730364)
29. Hunt R, Fedorak R, Frohlich J, McLennan C, Pavilanis A. Therapeutic role of dietary fibre. Can Fam Physician. 1993 ; 39: 897 903-900 910
30. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. 2 nd ed.New York: John Wiley; 1996. Leung AY Foster S, ed. New York: John Wiley ; 1996 :
31. Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens. 2007 ; 29: 383-394 (Pubitemid 47345885)
32. Sartore G, Reitano R, Barison A, et al. The effects of psyllium on lipoproteins in type II diabetic patients. Eur J Clin Nutr. 2009 ; 63: 1269-1271
33. Pal S, Khossousi A, Binns C, Dhaliwal S, Ellis V. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals. Br J Nutr. 2011 ; 105: 90-100
34. Salas-Salvadó J, Farrés X, Luque X, et al. Fiber in Obesity-Study Group: effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. Br J Nutr. 2008 ; 99: 1380-1387
35. Rodríguez-Morán M, Guerrero-Romero F, Lazcano-Burciaga G. Lipid- and glucose-lowering efficacy of Plantago psyllium in type II diabetes. J Diabetes Complications. 1998 ; 12: 273-278 (Pubitemid 28423398)
36. Giacosa A, Rondanelli M. The right fiber for the right disease: an update on the psyllium seed husk and the metabolic syndrome. J Clin Gastroenterol. 2010 ; 44: S58 - S60
37. Ziai SA, Larijani B, Akhoondzadeh S, et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 2005 ; 102: 202-207 (Pubitemid 41483558)
38. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999 ; 69: 30-42 (Pubitemid 29031248)
39. Keithley J, Swanson B. Glucomannan and obesity: a critical review. Altern Ther Health Med. 2005 ; 11: 30-34 (Pubitemid 43885299)
40. Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int J Obes. 1984 ; 8: 289-293 (Pubitemid 14020743)
41. Wood RJ, Fernandez ML, Sharman MJ, et al. Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk. Metabolism. 2007 ; 56: 58-67 (Pubitemid 44855013)
42. Vuksan V, Sievenpiper JL, Owen R, et al. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care. 2000 ; 23: 9-14 (Pubitemid 30022886)
43. Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes: a randomized controlled metabolic trial. Diabetes Care. 1999 ; 22: 913-919 (Pubitemid 29241044)
44. Lenz TL, Hamilton WR. Supplemental products used for weight loss. J Am Pharm Assoc. 2004 ; 44: 59-67
45. Gallaher CM, Munion J, Hesslink R, Wise J, Gallaher DD. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J Nutr. 2000 ; 130: 2753-2759
46. Gallaher DD, Gallaher CM, Mahrt GJ, Carr TP, Hollingshead CH, Hesslink R, Wise J. A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. J Am Coll Nutr. 2002 ; 21: 428-433
47. Wydro P, Krajewska B, Hac-Wydro K. Chitosan as a lipid binder: a langmuir monolayer study of chitosan-lipid interactions. Biomacromolecules. 2007 ; 8: 2611-2617 (Pubitemid 47317004)
48. Mhurchu CN, Dunshea-Mooij C, Bennett D, Rodgers A. Effect of chitosan on weight loss in overweight and obese individuals: a systematic review of randomized controlled trials. Obes Rev. 2005 ; 6: 35-42
49. Mhurchu CN, Poppitt SD, McGill AT, et al. The effect of the dietary supplement, chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. Int J Obes Relat Metab Disord. 2004 ; 28: 1149-1156 (Pubitemid 39141553)
50. Hernández-González SO, González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA. Chitosan improves insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique in obese subjects. Nutr Res. 2010 ; 30: 392-395
51. Pittler MH, Abbot NC, Harkness EF, Ernst E. Randomized, double-blind trial of chitosan for body weight reduction. Eur J Clin Nutr. 1999 ; 53 (5). 379-381 (Pubitemid 29243433)
52. Ho SC, Tai ES, Eng PH, Tan CE, Fok AC. In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects. Singapore Med J. 2001 ; 42 (1). 6-10 (Pubitemid 32225641)
53. Jull AB, Ni Mhurchu C, Bennett DA, Dunshea-Mooij CA, Rodgers A. Chitosan for overweight or obesity. Cochrane Database Syst Rev. 2008 ; ( 3 ):
54. Wuolijoki E, Hirvelä T, Ylitalo P. Decrease in serum LDL cholesterol with microcrystalline chitosan. Methods Find Exp Clin Pharmacol. 1999 ; 21: 357-361 (Pubitemid 29291252)
55. Schiller RN, Barrager E, Schauss AG, Nichols EJ. A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals. J Am Nutraceut Assn. 2001 ; 4: 42-49
56. Kaats GR, Michalek JE, Preuss HG. Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol. J Am Coll Nutr. 2006 ; 25: 389-394 (Pubitemid 44522575)
57. Kovacs EM, Westerterp-Plantenga MS, Saris WH, Goossens I, Geurten P, Brouns F. The effect of addition of modified guar gum to a low-energy semisolid meal on appetite and body weight loss. Int J Obes Relat Metab Disord. 2001 ; 25: 307-315 (Pubitemid 32209804)
58. Evans E, Miller DS. Bulking agents in the treatment of obesity. Nutr Metab. 1975 ; 18: 199-203
59. Kovacs EM, Westerterp-Plantenga MS, Saris WH, et al. The effect of guar gum addition to a semisolid meal on appetite related to blood glucose, in dieting men. Eur J Clin Nutr. 2002 ; 56: 771-778
60. Lyly M, Liukkonen KH, Salmenkallio-Marttila M, Karhunen L, Poutanen K, Lähteenmäki L. Fibre in beverages can enhance perceived satiety. Eur J Nutr. 2009 ; 48: 251-258
61. Pittler MH, Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med. 2001 ; 110: 724-730 (Pubitemid 32524322)
62. McCarty MF. Promotion of hepatic lipid oxidation and gluconeogenesis as a strategy for appetite control. Med Hypotheses. 1994 ; 42: 215-225 (Pubitemid 24146394)
63. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998 ; 280: 1596-1600 (Pubitemid 28520648)
64. Vasques CA, Rossetto S, Halmenschlager G, et al. Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity. Phytother Res. 2008 ; 22: 1135-1140
65. Kovacs EM, Westerterp-Plantenga MS, de Vries M, Brouns F, Saris WH. Effects of 2-week ingestion of (-)-hydroxycitrate and (-)-hydroxycitrate combined with medium-chain triglycerides on satiety and food intake. Physiol Behav. 2001 ; 74: 543-549 (Pubitemid 34076600)
66. Preuss HG, Garis RI, Bramble JD, et al. Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control. Int J Clin Pharmacol Res. 2005 ; 25: 133-144 (Pubitemid 41719437)
67. Kriketos AD, Thompson HR, Greene H, Hill JO. (-)-Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state. Int J Obes Relat Metab Disord. 1999 ; 23: 867-873 (Pubitemid 29378263)
68. Lim K, Ryu S, Nho HS, et al. (-)-Hydroxycitric acid ingestion increases fat utilization during exercise in untrained women. J Nutr Sci Vitaminol (Tokyo). 2003 ; 49: 163-167 (Pubitemid 36898615)
69. Preuss HG, Rao CV, Garis R, et al. An overview of the safety and efficacy of a novel, natural (-)-hydroxycitric acid extract (HCA-SX) for weight management. J Med. 2004 ; 35: 33-48 (Pubitemid 47578939)
70. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006 ; 17: 789-810 (Pubitemid 44738517)
71. Plourde M, Jew S, Cunnane SC, Jones PJ. Conjugated linoleic acids: why the discrepancy between animal and human studies?. Nutr Rev. 2008 ; 66: 415-421 (Pubitemid 352000152)
72. Kanaya N, Chen S. Conjugated linoleic acid reduces body weight gain in ovariectomized female C57BL/6J mice. Nutr Res. 2010 ; 30: 714-721
73. Joseph SV, Liu X, Wakefield A, et al. Trans-8, cis-10+ cis-9, trans-11-conjugated linoleic acid mixture alters body composition in Syrian golden hamsters fed a hypercholesterolaemic diet. Br J Nutr. 2010 ; 104: 1443-1449
74. Wendel AA, Purushotham A, Liu LF, Belury MA. Conjugated linoleic acid induces uncoupling protein 1 in white adipose tissue of ob/ob mice. Lipids. 2009 ; 44: 975-982
75. Parra P, Serra F, Palou A. Moderate doses of conjugated linoleic acid isomers mix contribute to lowering body fat content maintaining insulin sensitivity and a noninflammatory pattern in adipose tissue in mice. J Nutr Biochem. 2010 ; 21: 107-115
76. Halade GV, Rahman MM, Williams PJ, Fernandes G. Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice. J Nutr Biochem. 2011 ; 22: 459-469
77. Larsen TM, Toubro S, Gudmundsen O, Astrup A. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am J Clin Nutr. 2006 ; 83: 606-612 (Pubitemid 44699206)
78. Malpuech-Brugère C, Verboeket-van de Venne WP, Mensink RP, et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res. 2004 ; 12: 591-598 (Pubitemid 41132501)
79. Venkatramanan S, Joseph SV, Chouinard PY, Jacques H, Farnworth ER, Jones PJ. Milk enriched with conjugated linoleic acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals. J Am Coll Nutr. 2010 ; 29: 152-159
80. Whigham LD, Watras AC, Schoeller DA. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr. 2007 ; 85: 1203-1211 (Pubitemid 46740460)
81. Gaullier JM, Halse J, Høye K, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr. 2004 ; 79: 1118-1125 (Pubitemid 41095966)
82. Watras AC, Buchholz AC, Close RN, Zhang Z, Schoeller DA. The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. Int J Obes (Lond). 2007 ; 31: 481-487
83. Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci. 2007 ; 81: 519-533 (Pubitemid 47212236)
84. Perva-Uzunali A, Akerget M, Knez A, Weinreich B, Otto F, Grüner S. Extraction of active ingredients from green tea (Camellia sinensis): extraction efficiency of major catechins and caffeine. Food Chem. 2006 ; 96: 597-605 (Pubitemid 41737708)
85. Cross SE, Jin YS, Lu QY, Rao J, Gimzewski JK. Green tea extract selectively targets nanomechanics of live metastatic cancer cells. Nanotechnology. 2011 ; 22: 215101
86. Roy AM, Baliga MS, Katiyar SK. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther. 2005 ; 4: 81-90 (Pubitemid 40268069)
87. Sadava D, Whitlock E, Kane SE. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem Biophys Res Commun. 2007 ; 360: 233-237 (Pubitemid 46994711)
88. Tran PL, Kim SA, Choi HS, Yoon JH, Ahn SG. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo. BMC Cancer. 2010 ; 10: 276
89. Ikeda I. Multifunctional effects of green tea catechins on prevention of the metabolic syndrome. Asia Pac J Clin Nutr. 2008 ; 17: 273-274
90. Wang H, Wen Y, Du Y, et al. Effects of catechin enriched green tea on body composition. Obesity. 2010 ; 18: 773-779
91. Nagao T, Meguro S, Hase T, et al. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity. 2009 ; 17: 310-317
92. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity. 2007 ; 15: 1473-1483 (Pubitemid 47110911)
93. Maki KC, Reeves MS, Farmer M, et al. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr. 2009 ; 139: 264-270
94. Nagao T, Komine Y, Soga S, et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr. 2005 ; 81: 122-129 (Pubitemid 43073384)
95. Rains TM, Agarwal S, Maki KC. Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem. 2011 ; 22: 1-7
96. Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes. 2009 ; 33: 956-961
97. Diepvens K, Kovacs EM, Vogels N, Westerterp-Plantenga MS. Metabolic effects of green tea and of phases of weight loss. Physiol Behav. 2006 ; 87: 185-191 (Pubitemid 41797739)
98. Diepvens K, Kovacs EM, Nijs IM, Vogels N, Westerterp-Plantenga MS. Effect of green tea on resting energy expenditure and substrateoxidation during weight loss in overweight females. Br J Nutr. 2005 ; 94: 1026-1034 (Pubitemid 43092437)
99. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res. 2005 ; 13: 1195-1204
100. Astrup A, Toubro C, Cannon S, Hein P, Breum L, Madsen J. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr. 1990 ; 51: 759-767
101. He RR, Chen L, Lin BH, Matsui Y, Yao XS, Kurihara H. Beneficial effects of oolong tea consumption on diet-induced overweight and obese subjects. Chin J Integr Med. 2009 ; 15: 34-41
102. Han LK, Takaku T, Li J, Kimura Y, Okuda H. Anti-obesity action of oolong tea. Int J Obes Relat Metab Disord. 1999 ; 23 (1). 98-105 (Pubitemid 29008405)
103. Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010 ; 75: R77 - R87
104. Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, Coleman CI. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr. 2010 ; 91: 73-81
105. Astrup A, Breum L, Toubro S, Hein P, Quaade F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet: a double blind trial. Int J Obes Relat Metab Disord. 1992 ; 16: 269-277
106. Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB. Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr. 2006 ; 83: 674-680 (Pubitemid 44699215)
107. Dulloo A, Geissler C, Horton T, Miller D. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr. 1989 ; 49: 44-50 (Pubitemid 19042965)
108. Horst K, Willson RJ, Smith RG. The effect of coffee and decaffeinated coffee on oxygen consumption, pulse rate and blood pressure. J Pharmacol Exp Ther. 1936 ; 58: 294-304
109. Acheson KJ, Zahorska-Markiewicz B, Anantharaman K, Jequier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr. 1980 ; 33: 989-997 (Pubitemid 10040630)
110. Benowitz NL, Jacob P, Mayan H, Denaro C. Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther. 1995 ; 58: 684-691 (Pubitemid 26018853)
111. Kraemer WJ, Volek JS, Dunn-Lewis C. L-carnitine supplementation: influence upon physiological function. Curr Sports Med Rep. 2008 ; 7: 218-223
112. Hathcock JN, Shao A. Risk assessment for carnitine. Regul Toxicol Pharmacol. 2006 ; 46: 23-28 (Pubitemid 44293047)
113. Karlic H, Lohninger A. Supplementation of L-carnitine in athletes: does it make sense?. Nutrition. 2004 ; 20: 709-715 (Pubitemid 38798089)
114. Müller DM, Seim H, Kiess W, Löster H, Richter T. Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism. 2002 ; 51: 1389-1391
115. Ronnett GV, Kim EK, Landree LE, Tu Y. Fatty acid metabolism as a target for obesity treatment. Physiol Behav. 2005 ; 85: 25-35 (Pubitemid 40744974)
116. Ji H, Friedman MI. Reduced capacity for fatty acid oxidation in rats with inherited susceptibility to diet-induced obesity. Metabolism. 2007 ; 56: 1124-1130 (Pubitemid 47021179)
117. Fabris R, Mingrone G, Milan G, et al. Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion. J Clin Endocrinol Metab. 2004 ; 89: 1753-1759 (Pubitemid 38507930)
118. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol. 1999 ; 277: E1130 - E1141
119. Melton SA, Keenan MJ, Stanciu CE, et al. L-carnitine supplementation does not promote weight loss in ovariectomized rats despite endurance exercise. Int J Vitam Nutr Res. 2005 ; 75 (2). 156-160 (Pubitemid 40637743)
120. Saldanha Aoki M, Rodriguez Amaral Almeida AL, Navarro F, Bicudo Pereira Costa-Rosa LF, Pereira Bacurau RF. Carnitine supplementation fails to maximize fat mass loss induced by endurance training in rats. Ann Nutr Metab. 2004 ; 48: 90-94 (Pubitemid 38490248)
121. Brandsch C, Eder K. Effect of L-carnitine on weight loss and body composition of rats fed a hypocaloric diet. Ann Nutr Metab. 2002 ; 46: 205-210 (Pubitemid 36151264)
122. Hongu N, Sachan DS. Caffeine, carnitine and choline supplementation of rats decreases body fat and serum leptin concentration as does exercise. J Nutr. 2000 ; 130: 152-157 (Pubitemid 30073787)
123. Wutzke KD, Lorenz H. The effect of L-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects. Metabolism. 2004 ; 53: 1002-1006 (Pubitemid 38988283)
124. Elmslie JL, Porter RJ, Joyce PR, Hunt PJ, Mann JI. Carnitine does not improve weight loss outcomes in valproate-treated bipolar patients consuming an energy-restricted, low-fat diet. Bipolar Disord. 2006 ; 8: 503-507 (Pubitemid 44560225)
125. Villani RG, Gannon J, Self M, Rich PA. L-carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int J Sport Nutr Exerc Metab. 2000 ; 10: 199-207 (Pubitemid 30418879)
126. Center SA, Harte J, Watrous D, et al. The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral L-carnitine. J Vet Intern Med. 2000 ; 14: 598-608
127. Rubin MR, Volek JS, Gómez AL, et al. Safety measures of L-carnitine L-tartrate supplementation in healthy men. J Strength Cond Res. 2001 ; 15: 486-490 (Pubitemid 33658587)
128. Abourashed EA, El-Alfy AT, Khan IA, Walker L. Ephedra in perspective: a current review. Phytother Res. 2003 ; 17: 703-712
129. Chen WL, Tsai TH, Yang CC, Kuo TB. Effects of ephedra on autonomic nervous modulation in healthy young adults. J Ethnopharmacol. 2010 ; 130: 563-568
130. Andraws R, Chawla P, Brown DL. Cardiovascular effects of ephedra alkaloids: a comprehensive review. Prog Cardiovasc Dis. 2005 ; 47: 217-225 (Pubitemid 40854178)
131. Greenway FL. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obes Rev. 2001 ; 2: 199-211 (Pubitemid 33755913)
132. Jonderko K, Kucio C. Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients. Aliment Pharmacol Ther. 1991 ; 5: 413-418
133. Dulloo AG, Miller DS. Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity. Am J Clin Nutr. 1987 ; 45: 564-569 (Pubitemid 17046211)
134. Breum L, Pedersen JK, Ahlstrøm F, Frimodt-Møller J. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity: a double-blind multi-centre trial in general practice. Int J Obes Relat Metab Disord. 1994 ; 18: 99-103 (Pubitemid 24056313)
135. Coffey CS, Steiner D, Baker BA, Allison DB. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. Int J Obes Relat Metab Disord. 2004 ; 28: 1411-1419 (Pubitemid 39481844)
136. Boozer CN, Daly PA, Homel P, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord. 2002 ; 26: 593-604 (Pubitemid 34499277)
137. Greenway FL. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obes Rev. 2001 ; 2: 199-211 (Pubitemid 33755913)
138. Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003 ; 289: 1537-1545 (Pubitemid 37430293)
139. Seamon MJ, Clauson KA. Ephedra: yesterday, DSHEA, and tomorrow: a ten year perspective on the Dietary Supplement Health and Education Act of 1994. J Herb Pharmacother. 2005 ; 5: 67-86 (Pubitemid 43933104)
140. Castot A, Larrey D. Hepatitis observed during a treatment with a drug or tea containing wild germander: evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance [in French]. Gastroenterol Clin Biol. 1992 ; 16: 916-922
141. Larrey D, Vial T, Pauwels A, Castot A, Biour M, David M, Michel H. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med. 1992 ; 117: 129-132
142. Loeper J, Descatoire V, Letteron P, et al. Hepatotoxicity of germander in mice. Gastroenterology. 1994 ; 106: 464-447
143. Lekehal M, Pessayre D, Lereau JM, Moulis C, Fouraste I, Fau D. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology. 1996 ; 24: 212-218 (Pubitemid 26249436)
144. Luo XJ, Peng J, Li YJ. Recent advances in the study on capsaicinoids and capsinoids. Eur J Pharmacol. 2011 ; 650: 1-7
145. Snitker S, Fujishima Y, Shen H, et al. Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. Am J Clin Nutr. 2009 ; 89: 45-50
146. Josse AR, Sherriffs SS, Holwerda AM, Andrews R, Staples AW, Phillips SM. Effects of capsinoid ingestion on energy expenditure and lipid oxidation at rest and during exercise. Nutr Metab (Lond). 2010 ; 7: 65
147. Westerterp-Plantenga MS, Smeets A, Lejeune MP. Sensory and gastrointestinal satiety effects of capsaicin on food intake. Int J Obes. 2005 ; 29: 682-688 (Pubitemid 40769490)
148. Ludy MJ, Mattes RD. The effects of hedonically acceptable red pepper doses on thermogenesis and appetite. Physiol Behav. 2011 ; 102: 251-258
149. Belza A, Frandsen E, Kondrup J. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects. Int J Obes (Lond). 2007 ; 31: 121-130 (Pubitemid 46006025)
150. Joo JI, Kim DH, Choi JW, Yun JW. Proteomic analysis for antiobesity potential of capsaicin on white adipose tissue in rats fed with a high fat diet. J Proteome Res. 2010 ; 9: 2977-2987
151. Lee RA, Balick MJ. Indigenous use of Hoodia gordonii and appetite suppression. Explore (NY). 2007 ; 3: 404-406 (Pubitemid 47189130)
152. MacLean DB, Luo LG. Increased ATP content/production in the hypothalamus may be a signal for energy-sensing of satiety: studies of the anorectic mechanism of a plant steroidal glycoside. Brain Res. 2004 ; 1020: 1-11 (Pubitemid 39092965)
153. Habeck M. A succulent cure to end obesity. Drug Discov Today. 2002 ; 7: 280-281 (Pubitemid 34195417)
154. Oliver-Bever B. Medicinal plants in tropical West Africa, III: anti-infection therapy with higher plants. J Ethnopharmacol. 1983 ; 9: 1-83 (Pubitemid 14197663)
155. Oliver-Bever B. Medicinal plants in tropical West Africa, II: plants acting on the nervous system. J Ethnopharmacol. 1983 ; 7: 1-93
156. Oliver-Bever B. Medicinal plants in tropical West Africa, I: plants acting on the cardiovascular system. J Ethnopharmacol. 1982 ; 5: 1-72
157. Oben JE, Ngondi JL, Momo CN, Agbor GA, Sobgui CS. The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008 ; 7: 12
158. Oben J, Kuate D, Agbor G, Momo C, Talla X. The use of a Cissus
159. Oben JE, Enyegue DM, Fomekong GI, Soukontoua YB, Agbor GA. The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 2007 ; 6: 4
160. Haaz S, Fontaine KR, Cutter G, Limdi N, Perumean-Chaney S, Allison DB. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev. 2006 ; 7: 79-88
161. Greenway F, de Jonge-Levitan L, Martin C, Roberts A, Grundy I, Parker C. Dietary herbal supplements with phenylephrine for weight loss. J Med Food. 2006 ; 9: 572-578 (Pubitemid 46095369)
162. Preuss HG, DiFerdinando D, Bagchi M, Bagchi D. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. J Med. 2002 ; 33: 247-264 (Pubitemid 36896783)
163. Colker CM, Kalman DS, Torina GC, Perlis T, Street C. Effects of citrus aurantium extract, caffeine, and St. John's wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Curr Ther Res. 1999 ; 60: 145-153 (Pubitemid 29152843)
164. Asnaashari S, Delazar A, Habibi B, et al. Essential oil from Citrus aurantifolia prevents ketotifen-induced weight-gain in mice. Phytother Res. 2010 ; 24: 1893-1897
165. Dangerous supplements: what you don't know about these 12 ingredients could hurt you. Consum Rep. 2010 ; 75: 16-20
166. Madar Z, Stark AH. New legume sources as therapeutic agents. Br J Nutr. 2002 ; 88: S287 - S292
167. Hannan JM, Ali L, Rokeya B, et al. Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr. 2007 ; 97: 514-521 (Pubitemid 46662041)
168. Xue WL, Li XS, Zhang J, Liu YH, Wang ZL, Zhang RJ. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr. 2007 ; 16: 422-426 (Pubitemid 46524638)
169. Annida B, Stanely Mainzen Prince P. Supplementation of fenugreek leaves reduces oxidative stress in streptozotocin-induced diabetic rats. J Med Food. 2005 ; 8: 382-385 (Pubitemid 41502423)
170. Dixit P, Ghaskadbi S, Mohan H, Devasagayam TP. Antioxidant properties of germinated fenugreek seeds. Phytother Res. 2005 ; 19: 977-983 (Pubitemid 41820238)
171. Dakam W, Shang J, Agbor G, Oben J. Effects of sodium bicarbonate and albumin on the in vitro water-holding capacity and some physiological properties of Trigonella foenum graecum L. galactomannan in rats. J Med Food. 2007 ; 10 (1). 169-174 (Pubitemid 46706865)
172. Bin-Hafeez B, Haque R, Parvez S, Pandey S, Sayeed I, Raisuddin S. Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in mice. Int Immunopharmacol. 2003 ; 3: 257-265 (Pubitemid 36183384)
173. Sharma RD, Raghuram TC, Rao NS. Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes. Eur J Clin Nutr. 1990 ; 44: 301-306 (Pubitemid 20177218)
174. Gupta A, Gupta R, Lal B. Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India. 2001 ; 49: 1057-1061 (Pubitemid 33645101)
175. Kassaian N, Azadbakht L, Forghani B, Amini M. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. Int J Vitam Nutr Res. 2009 ; 79: 34-39
176. Chevassus H, Gaillard JB, Farret A, et al. A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects. Eur J Clin Pharmacol. 2010 ; 66: 449-455
177. Chevassus H, Molinier N, Costa F, Galtier F, Renard E, Petit P. A fenugreek seed extract selectively reduces spontaneous fat consumption in healthy volunteers. Eur J Clin Pharmacol. 2009 ; 65: 1175-1178
178. Barrett ML, Udani JK. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J. 2011 ; 10: 24
179. Udani J, Singh BB. Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract. Altern Ther Health Med. 2007 ; 13: 32-37 (Pubitemid 351299280)
180. Udani J, Hardy M, Madsen DC. Blocking carbohydrate absorption and weight loss: a clinical trial using phase 2 brand proprietary fractionated white bean extract. Altern Med Rev. 2004 ; 9: 63-69 (Pubitemid 38364882)
181. Celleno L, Tolaini MV, D'Amore A, Perricone NV, Preuss HG. A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci. 2007 ; 4: 45-52 (Pubitemid 46168687)
182. Mollah ML, Kim GS, Moon HK, et al. Antiobesity effects of wild ginseng (Panax ginseng C.A. Meyer) mediated by PPAR-gamma, GLUT4 and LPL in ob/ob mice. Phytother Res. 2009 ; 23: 220-225
183. Kim HY, Kang KS, Yamabe N, Nagai R, Yokozawa T. Protective effect of heat-processed American ginseng against diabetic renal damage in rats. J Agric Food Chem. 55 (21). 8491-8497
184. Lian XY, Zhang Z, Stringer JL. Protective effects of ginseng components in a rodent model of neurodegeneration. Ann Neurol. 2005 ; 57: 642-648 (Pubitemid 40628852)
185. Xie JT, Zhou YP, Dey L, et al. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine. 2002 ; 9: 254-258 (Pubitemid 34475559)
186. Lim S, Yoon JW, Choi SH, et al. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model. Metabolism. 2009 ; 58: 8-15
187. Kim JH, Kang SA, Han SM, Shim I. Comparison of the antiobesity effects of the protopanaxadiol- and protopanaxatriol-type saponins of red ginseng. Phytother Res. 2009 ; 23: 78-85
188. Han LK, Zheng YN, Yoshikawa M, Okuda H, Kimura Y. Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complement Altern Med. 2005 ; 5: 9
189. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care. 1995 ; 18: 1373-1375